Riskpilot← Back to searchSign inGet full accessMarcus Davidsson Consulting AB
ABActiveOrg 5593510851Economic activity was not specified by tax authority · NACE 0000Est. 20210 employees
Revenue 2024
SEK 0
EBITDA margin
—
+4% vs 2023
Equity ratio
98.8%
Financial strength
Net profit 2024
SEK 1,7M
+14136% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -12K | +4% |
| Net profit | SEK 1,7M | +14136% |
| Total assets | SEK 2,3M | +201% |
| Equity | SEK 2,3M | +209% |
| Employees | 0 | — |
Legal name
Marcus Davidsson Consulting AB
Org number
5593510851
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
6 december 2021
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom forskning, utveckling, rådgivning, undervisning och förtroendeuppdrag inom det medicinska området, delta i förvaltning i dotterbolagen samt därmed förenlig verksamhet.
Address
Email
marcus.davidsson@raaven.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | — | — | — |
| EBITDA | −18 | −12 | −12 |
| Depreciation & amort. | — | — | — |
| EBIT | −18 | −12 | −12 |
| Net financials | 994 | — | 1 754 |
| Profit before tax | 976 | −12 | 1 742 |
| Tax | — | — | — |
| Net profit | 976 | −12 | 1 742 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 1 028 | 766 | 2 308 |
| Equity | 1 001 | 739 | 2 281 |
| Long-term debt | — | — | — |
| Short-term debt | 27 | 27 | 27 |
| Total debt | 27 | 27 | 27 |
EBITDA margin
-1195400.0%
This company
15.8%
Market median
-7565923% vs market
20222024
Equity ratio
98.8%
This company
38.2%
Market median
+159% vs market
20222024
Return on equity
76.4%
This company
18.4%
Market median
+315% vs market
20222024
Net profit margin
174208700.0%
This company
8.1%
Market median
+2150724591% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20222024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Marcus Davidsson Consulting AB 
Raaven Therapeutics ABBoard members of Marcus Davidsson Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Staffan Marcus Davidsson | Board of Directors | 0 companies |
| Henrik Andreas Davidsson | Deputy Board Member | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Deputy Board Member | 0 companies |